ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Cytokinetics, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 9.54% and Operating profit at -235.20% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -6.17
2
Flat results in Mar 26
- OPERATING CASH FLOW(Y) Lowest at USD -523.85 MM
- NET SALES(Q) At USD 19.36 MM has Fallen at -12.06%
- INTEREST(Q) Highest at USD 33.34 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 106.61%, its profits have fallen by -16.9%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Cytokinetics, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Cytokinetics, Inc.
106.61%
0.43
62.00%
S&P 500
22.99%
1.78
12.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.54%
EBIT Growth (5y)
-235.20%
EBIT to Interest (avg)
-6.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.98
Sales to Capital Employed (avg)
0.07
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-11.67
EV to EBIT
-13.05
EV to EBITDA
-13.27
EV to Capital Employed
-21.67
EV to Sales
90.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
NET SALES(HY)
At USD 37.11 MM has Grown at 100.53%
NET PROFIT(HY)
Higher at USD -403.16 MM
RAW MATERIAL COST(Y)
Fallen by -246.51% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -56.51 %
INVENTORY TURNOVER RATIO(HY)
Highest at 178.64 times
-17What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -523.85 MM
NET SALES(Q)
At USD 19.36 MM has Fallen at -12.06%
INTEREST(Q)
Highest at USD 33.34 MM
OPERATING PROFIT(Q)
Lowest at USD -180.24 MM
PRE-TAX PROFIT(Q)
Lowest at USD -205.93 MM
NET PROFIT(Q)
Lowest at USD -205.93 MM
Here's what is working for Cytokinetics, Inc.
Debt-Equity Ratio
Lowest at -56.51 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 178.64 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -246.51% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 3.38 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Cytokinetics, Inc.
Operating Cash Flow
Lowest at USD -523.85 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Net Sales
At USD 19.36 MM has Fallen at -12.06%
over average net sales of the previous four periods of USD 22.01 MMMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Interest
Highest at USD 33.34 MM
in the last five periods and Increased by 9.89% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Profit
Lowest at USD -180.24 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -205.93 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD -205.93 MM has Fallen at -23.37%
over average net sales of the previous four periods of USD -166.93 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -205.93 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Net Profit
At USD -205.93 MM has Fallen at -23.37%
over average net sales of the previous four periods of USD -166.93 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
